| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.46B | 53.73B | 51.71B | 45.73B | 40.64B | 35.42B |
| Gross Profit | 21.51B | 20.32B | 19.46B | 15.61B | 15.54B | 12.89B |
| EBITDA | 8.57B | 8.28B | 8.40B | 6.22B | 7.08B | 5.23B |
| Net Income | 5.26B | 4.80B | 4.65B | 2.96B | 3.33B | 1.28B |
Balance Sheet | ||||||
| Total Assets | 66.93B | 67.67B | 62.75B | 57.34B | 55.59B | 50.55B |
| Cash, Cash Equivalents and Short-Term Investments | 17.14B | 15.69B | 16.37B | 12.05B | 10.79B | 10.06B |
| Total Debt | 13.61B | 13.08B | 12.41B | 16.02B | 16.01B | 17.89B |
| Total Liabilities | 23.34B | 23.61B | 24.18B | 25.80B | 27.35B | 27.00B |
| Stockholders Equity | 43.58B | 44.05B | 38.57B | 31.54B | 28.24B | 23.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.24B | 7.31B | 1.01B | 1.88B | 3.63B |
| Operating Cash Flow | 0.00 | 2.92B | 10.15B | 3.90B | 5.03B | 5.84B |
| Investing Cash Flow | 0.00 | -4.32B | -2.90B | -2.79B | -3.06B | -2.48B |
| Financing Cash Flow | 0.00 | -6.00M | -4.09B | -461.00M | -2.13B | -2.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥55.50B | 12.25 | ― | 2.52% | 2.47% | 6.88% | |
76 Outperform | ¥178.99B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
75 Outperform | ¥40.04B | 8.19 | ― | 2.83% | 2.27% | 24.78% | |
72 Outperform | ¥183.18B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
67 Neutral | ¥66.82B | 31.55 | 1.61% | 2.27% | 1.82% | -32.79% | |
63 Neutral | ¥39.93B | 8.04 | ― | 1.90% | 6.70% | 53.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |